Catalyst Pharmaceuticals
CPRX
#3695
Rank
โ‚ฌ3.36 B
Marketcap
27,50ย โ‚ฌ
Share price
0.03%
Change (1 day)
53.14%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: โ‚ฌ3.36 Billion

As of July 2026 Catalyst Pharmaceuticals has a market cap of โ‚ฌ3.36 Billion. This makes Catalyst Pharmaceuticals the world's 3695th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ3.36 B32.13%
2025โ‚ฌ2.54 B3.53%
2024โ‚ฌ2.46 B51.8%
2023โ‚ฌ1.62 B-10.16%
2022โ‚ฌ1.80 B193.1%
2021โ‚ฌ0.61 B118.47%
2020โ‚ฌ0.28 B-18.58%
2019โ‚ฌ0.34 B100.73%
2018โ‚ฌ0.17 B-48.36%
2017โ‚ฌ0.33 B303.54%
2016โ‚ฌ82.75 M-55.42%
2015โ‚ฌ0.18 B9.99%
2014โ‚ฌ0.16 B120.82%
2013โ‚ฌ76.43 M461.15%
2012โ‚ฌ13.62 M-44.49%
2011โ‚ฌ24.53 M69.98%
2010โ‚ฌ14.43 M81.99%
2009โ‚ฌ7.93 M-56.19%
2008โ‚ฌ18.1 M-38.84%
2007โ‚ฌ29.6 M-35.39%
2006โ‚ฌ45.81 M

End of Day market cap according to different sources

On Jul 1st, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

โ‚ฌ3.36 Billion
by Nasdaq info icon info icon
โ‚ฌ3.36 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ553.66 B 16,346.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ121.20 B 3,500.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ145.29 B 4,216.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ1.77 B-47.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ0.71 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ9.96 B 196.15%๐Ÿ‡บ๐Ÿ‡ธ USA